Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Celltex Therapeutics Corporation
WARNING LETTER
•Celltex Therapeutics Corporation•April 27, 2012

Celltex Therapeutics Corporation – FDA Warning Letter, Apr 27, 2012

Record Details

On September 24, 2012, the FDA issued a Warning Letter to CellTex Therapeutics Corporation following an inspection from April 16-27, 2012. The FDA determined CellTex processes autologous adipose tissue to isolate, select, and expand adipose-derived mesenchymal stem cells (AdMSC) for patient administration across various indications, promoting these uses through clinical trials.

The FDA classified CellTex's product as a human cell, tissue, or cellular and tissue-based product (HCT/P) under 21 CFR 1271.3(d). However, the processing, including cell culture and expansion, was deemed to alter the original relevant characteristics of the adipose tissue, failing to meet the "minimal manipulation" definition (21 CFR 1271.3(f)(1)). Additionally, the clinical uses were not considered "homologous use" (21 CFR 1271.3(c)). Consequently, the product does not meet criteria for regulation solely under Section 361 of the PHS Act and 21 CFR Part 1271.

The FDA concluded that CellTex's promotion causes the AdMSC product to be a drug and biological product, requiring a valid biologics license or an Investigational New Drug (IND) application. Since neither was in effect, the product violates the FDC Act and PHS Act.

The inspection also revealed significant

Company
Celltex Therapeutics Corporation
Inspection date
April 27, 2012
Product type
Biologics
Office
Center for Biologics Evaluation and Research
View Company Profile

ID · f06f5521-e0fd-437f-b732-bffb4da007b3

Violation Codes2
21 CFR 1271.290(c)21 CFR 1271.90(b)

Full citation text and observation details available on the Dashboard.

Other documents for Celltex Therapeutics Corporation
  • 483 - 2012-04-27April 27, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Celltex Therapeutics Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.